MedPath

Nefopam

Generic Name
Nefopam
Drug Type
Small Molecule
Chemical Formula
C17H19NO
CAS Number
13669-70-0
Unique Ingredient Identifier
4UP8060B7J
Background

Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.

Indication

用于术后镇痛、癌痛、急性外伤痛。亦可用于急性胃炎、胆道蛔虫症、输尿管结石等内脏平滑肌收缩绞痛;局部麻醉、针麻等麻醉辅助用药。

Associated Conditions
Pain

Effectiveness of Nefopam in Breast Cancer Surgery

Not Applicable
Conditions
Breast Neoplasm Malignant Primary
Interventions
Drug: Normal Saline
First Posted Date
2016-10-31
Last Posted Date
2018-01-11
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
88
Registration Number
NCT02949310
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia

Phase 2
Completed
Conditions
Laparotomy
Interventions
Drug: Saline
First Posted Date
2015-11-04
Last Posted Date
2015-11-05
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
73
Registration Number
NCT02596269

Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy

Not Applicable
Completed
Conditions
Thyroidectomy
Pain
Interventions
First Posted Date
2015-10-16
Last Posted Date
2019-03-21
Lead Sponsor
Yonsei University
Target Recruit Count
84
Registration Number
NCT02577068
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Preemptive Analgesic Efficacy of Nefopam

Not Applicable
Completed
Conditions
Breast Neoplasm
Interventions
Drug: Saline
First Posted Date
2015-09-28
Last Posted Date
2016-04-06
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
94
Registration Number
NCT02561468
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Postoperative Analgesic Effect of Nefopam

Not Applicable
Completed
Conditions
Stomach Neoplasms
Interventions
Drug: Saline
First Posted Date
2015-09-28
Last Posted Date
2016-10-28
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
78
Registration Number
NCT02561494
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia

Phase 4
Conditions
Cholecystitis
Interventions
First Posted Date
2015-07-09
Last Posted Date
2015-09-02
Lead Sponsor
Hallym University Kangnam Sacred Heart Hospital
Target Recruit Count
60
Registration Number
NCT02493231
Locations
🇰🇷

Hallym University Kangnam Sacred Heart Hospita, Seoul, Korea, Republic of

Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering

First Posted Date
2015-05-12
Last Posted Date
2018-07-17
Lead Sponsor
Lagos State Health Service Commission
Target Recruit Count
130
Registration Number
NCT02441673

Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia.

Phase 4
Terminated
Conditions
Post Operative Analgesia
Interventions
First Posted Date
2013-06-20
Last Posted Date
2018-02-06
Lead Sponsor
Rennes University Hospital
Target Recruit Count
223
Registration Number
NCT01882530
Locations
🇫🇷

Marcel Chauvin, Boulogne, France

🇫🇷

Xavier Capdevila, Montpellier, France

🇫🇷

Hawa Keita-Meyer, Colombes, France

and more 16 locations

The Analgesic Effect of Nefopam on the Fentanyl Based PCA (Patient-controlled Analgesia) After Lumbar Spinal Surgery

Not Applicable
Conditions
Lumbar Spinal Stenisis or Lumbar Herniated Intervertebral Disc
Interventions
First Posted Date
2013-03-08
Last Posted Date
2014-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
54
Registration Number
NCT01808014
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Effect of Nefopam on Remifentanil Induced Postoperative Hyperalgesia

Not Applicable
Completed
Conditions
Patients Undergoing Laparoscopic Gastrectomy
Interventions
First Posted Date
2012-11-26
Last Posted Date
2014-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
25
Registration Number
NCT01732666
Locations
🇰🇷

Severance hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath